How The Repligen (RGEN) Narrative Is Shifting With New Targets M&A Plans And Products [Yahoo! Finance]
Repligen Corporation (RGEN)
Last repligen corporation earnings: 2/20 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
repligen.com/investors
Company Research
Source: Yahoo! Finance
The updated fair value for Repligen is set at US$190.89, with analysts treating this as a recalibration of their existing price target rather than a fresh reset. Bullish and bearish voices are split on how much this US$190.89 level really tells you about upside from here, especially given the different views on how dependable the underlying assumptions are. As you read on, you will see how these price target debates, along with recent company news, shape the evolving narrative around Repligen and what it could mean for your own watchlist. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Repligen. What Wall Street Has Been Saying ?? Bullish Takeaways UBS, Evercore ISI, Wells Fargo and Barclays all maintain positive stances on Repligen, using ratings such as Buy, Outperform and Overweight even after revising their price targets. Wells Fargo highlights a solid Q4 performance on both revenue and earnings, with
Show less
Read more
Impact Snapshot
Event Time:
RGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGEN alerts
High impacting Repligen Corporation news events
Weekly update
A roundup of the hottest topics
RGEN
News
- A Look Back at Drug Development Inputs & Services Stocks' Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack [Yahoo! Finance]Yahoo! Finance
- 2 Growth Stocks Set to Flourishand 1 We Turn Down [Yahoo! Finance]Yahoo! Finance
- Repligen Corporation (RGEN) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]Seeking Alpha
- Reassessing Repligen (RGEN) Valuation After Sector Pullback And Profitability Concerns [Yahoo! Finance]Yahoo! Finance
- Evaluating Repligen (RGEN) After Sharp Share Price Declines and Conflicting Valuation Signals [Yahoo! Finance]Yahoo! Finance
RGEN
Earnings
- 2/24/26 - Beat
RGEN
Sec Filings
- 3/5/26 - Form 4
- 3/5/26 - Form 4
- 3/3/26 - Form 4
- RGEN's page on the SEC website